Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Journey Medical (DERM) Amortization - Intangibles (2024 - 2025)

Historic Amortization - Intangibles for Journey Medical (DERM) over the last 2 years, with Q3 2025 value amounting to $1.1 million.

  • Journey Medical's Amortization - Intangibles rose 3071.25% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $3.4 million for FY2024, which is 910.54% down from last year.
  • Journey Medical's Amortization - Intangibles amounted to $1.1 million in Q3 2025, which was up 3071.25% from $1.1 million recorded in Q2 2025.
  • Journey Medical's 5-year Amortization - Intangibles high stood at $1.1 million for Q1 2025, and its period low was $814000.0 during Q1 2024.